Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

3.32
Delayed Data
As of 2:06pm ET
 -0.175 / -5.01%
Today’s Change
2.31
Today|||52-Week Range
5.79
+24.16%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close3.49
Today’s open3.46
Day’s range3.30 - 3.49
Volume79,471
Average volume (3 months)214,269
Market cap$182.8M
Dividend yield--
Data as of 2:06pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)+41.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-89.73%
P/E ratioNM
Price/Sales434.52
Price/Book--

Competitors

 Today’s
change
Today’s
% change
BDSIBioDelivery Sciences...-0.13-3.79%
ALRNAileron Therapeutics...-0.30-2.42%
NLNKNewLink Genetics Cor...+0.14+2.20%
NEOSNeos Therapeutics In...+0.13+1.88%
Data as of 2:18pm ET, 08/21/2017

Financials

Last reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$283.6K
Annual profit (last year)-$13.1M
Net profit margin-4,622.39%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts